Lehrstuhl für Innere Medizin IV


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis (2021) Müller-Deile J, Jaremenko C, Haller H, Schiffer M, Haubitz M, Christiansen S, Falk C, Schiffer L Journal article Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis (2021) Mann J, Buse JB, Idorn T, Leiter LA, Pratley RE, Rasmussen S, Vilsboll T, et al. Journal article Prevalence of mental disorders in a German kidney transplant population - results of a KTx360 degrees-substudy (2021) Noehre M, Birkefeld K, Bauer-Hohmann M, Tun EMKT, Tegtbur U, Pape L, Schiffer L, et al. Conference contribution AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects? (2021) Rodionova K, Hindermann M, Hilgers KF, Ott C, Schmieder R, Schiffer M, Amann KU, et al. Journal article, Original article Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients (2021) Braunisch MC, Gundel P, Werfel S, Mayer CC, Bauer A, Haller B, Guenthner R, et al. Journal article Visualization of the epimysium and fascia thoracolumbalis at the lumbar spine using MRI (2021) Adamietz B, Schoenberg SO, Reiser M, Uder M, Frank A, Strecker R, Weiss C, Heiß R Journal article THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Bosch A, Jung S, Linz P, Kannenkeril D, Nagel AM, Ott C, et al. Conference contribution Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease (2021) Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, et al. Journal article EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D (2021) Ruilope L, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, et al. Conference contribution